Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cyclobenzaprine hydrochloride |
Is a |
False |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclobenzaprine measurement (procedure) |
Component |
True |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochlorid 10mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclobenzaprine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclobenzaprine hydrochloride |
Is modification of (attribute) |
True |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cyclobenzaprine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cyclobenzaprine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cyclobenzaprine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Cyclobenzaprine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |